Aethlon Medical, Inc. (AEMD)
USD 0.35
(-4.54%)
USD 0.35
(-4.54%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -11.84 Million USD | -1.64% |
| 2023 | -11.65 Million USD | -13.21% |
| 2022 | -10.29 Million USD | -31.15% |
| 2021 | -7.85 Million USD | -33.0% |
| 2020 | -6.29 Million USD | 1.08% |
| 2019 | -5.96 Million USD | -24.46% |
| 2018 | -5.3 Million USD | 20.94% |
| 2017 | -6.96 Million USD | -39.57% |
| 2016 | -4.34 Million USD | -9.88% |
| 2015 | -6.5 Million USD | -30.34% |
| 2014 | -12.98 Million USD | 14.87% |
| 2013 | -3.74 Million USD | -442.53% |
| 2012 | -4.3 Million USD | 114.23% |
| 2011 | -1.74 Million USD | -173.63% |
| 2010 | -2.99 Million USD | -275277.96% |
| 2009 | -4.29 Million USD | 100.06% |
| 2008 | -1.74 Million USD | -202.09% |
| 2007 | -5.61 Million USD | 230.57% |
| 2006 | -2.43 Million USD | 36.83% |
| 2005 | -2.07 Million USD | -138.87% |
| 2004 | -868.54 Thousand USD | 24.01% |
| 2003 | -1.14 Million USD | 38.95% |
| 2002 | -1.87 Million USD | -89.12% |
| 2001 | -1.86 Million USD | -63.07% |
| 2000 | -607.12 Thousand USD | -92.06% |
| 1999 | -316.12 Thousand USD | -8683.55% |
| 1998 | -431.05 Thousand USD | -134.62% |
| 1997 | -1534.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -3.08 Million USD | 7.05% |
| 2024 Q1 | -3.31 Million USD | -38.34% |
| 2024 Q4 | -2.4 Million USD | 30.68% |
| 2024 FY | - USD | -5.32% |
| 2024 Q3 | -2.6 Million USD | -9.45% |
| 2023 Q3 | -2.77 Million USD | 23.28% |
| 2023 Q1 | -2.87 Million USD | 23.53% |
| 2023 Q2 | -3.61 Million USD | -25.64% |
| 2023 FY | - USD | -13.21% |
| 2023 Q4 | -2.39 Million USD | 13.47% |
| 2022 FY | - USD | -31.15% |
| 2022 Q1 | -2.08 Million USD | 7.39% |
| 2022 Q2 | -1.93 Million USD | 7.04% |
| 2022 Q4 | -3.76 Million USD | -49.8% |
| 2022 Q3 | -2.51 Million USD | -29.41% |
| 2021 FY | - USD | -33.0% |
| 2021 Q2 | -1.76 Million USD | -25.72% |
| 2021 Q4 | -2.25 Million USD | 7.41% |
| 2021 Q3 | -2.43 Million USD | -38.11% |
| 2021 Q1 | -1.4 Million USD | 21.03% |
| 2020 Q4 | -1.77 Million USD | -104.91% |
| 2020 Q1 | -1.56 Million USD | 1.37% |
| 2020 FY | - USD | 1.08% |
| 2020 Q2 | -1.69 Million USD | -8.7% |
| 2020 Q3 | -866.16 Thousand USD | 49.03% |
| 2019 Q1 | -1.08 Million USD | 13.75% |
| 2019 Q2 | -1.33 Million USD | -22.94% |
| 2019 Q3 | -1.95 Million USD | -46.01% |
| 2019 Q4 | -1.58 Million USD | 18.93% |
| 2019 FY | - USD | -24.46% |
| 2018 FY | - USD | 20.94% |
| 2018 Q3 | -1.15 Million USD | 5.87% |
| 2018 Q2 | -1.22 Million USD | -6.6% |
| 2018 Q1 | -1.15 Million USD | 23.18% |
| 2018 Q4 | -1.26 Million USD | -9.35% |
| 2017 Q4 | -1.49 Million USD | -21.83% |
| 2017 FY | - USD | -39.57% |
| 2017 Q3 | -1.22 Million USD | 44.51% |
| 2017 Q2 | -2.21 Million USD | -97.63% |
| 2017 Q1 | -1.12 Million USD | -4.18% |
| 2016 FY | - USD | -9.88% |
| 2016 Q3 | -1.07 Million USD | 3.66% |
| 2016 Q2 | -1.11 Million USD | -3.18% |
| 2016 Q4 | -1.07 Million USD | -0.21% |
| 2016 Q1 | -1.08 Million USD | 3.8% |
| 2015 Q4 | -1.12 Million USD | -4.24% |
| 2015 FY | - USD | -30.34% |
| 2015 Q1 | -1.16 Million USD | -44.78% |
| 2015 Q2 | -591.85 Thousand USD | 49.1% |
| 2015 Q3 | -1.07 Million USD | -82.08% |
| 2014 Q1 | -781.36 Thousand USD | 7.47% |
| 2014 Q2 | -227.5 Thousand USD | 70.88% |
| 2014 Q3 | -1.22 Million USD | -437.53% |
| 2014 Q4 | -803.06 Thousand USD | 34.33% |
| 2014 FY | - USD | 14.87% |
| 2013 Q4 | -844.42 Thousand USD | 9.62% |
| 2013 FY | - USD | -442.53% |
| 2013 Q1 | -1.65 Million USD | -136.52% |
| 2013 Q2 | -797.07 Thousand USD | 51.71% |
| 2013 Q3 | -934.33 Thousand USD | -17.22% |
| 2012 FY | - USD | 114.23% |
| 2012 Q2 | -1.9 Million USD | -25.55% |
| 2012 Q1 | -1.51 Million USD | 68.78% |
| 2012 Q3 | -412.18 Thousand USD | 78.39% |
| 2012 Q4 | 4.51 Million USD | 1196.58% |
| 2011 Q4 | -4.86 Million USD | -501.69% |
| 2011 Q1 | 594.87 Thousand USD | 283.58% |
| 2011 FY | - USD | -173.63% |
| 2011 Q2 | -2.23 Million USD | -474.99% |
| 2011 Q3 | -808.84 Thousand USD | 63.74% |
| 2010 Q3 | -635.09 Thousand USD | 39.09% |
| 2010 Q4 | -324.03 Thousand USD | 48.98% |
| 2010 Q1 | -601.37 Thousand USD | -179.68% |
| 2010 Q2 | -1.04 Million USD | -73.37% |
| 2010 FY | - USD | -275277.96% |
| 2009 Q2 | 250.97 Thousand USD | 182.24% |
| 2009 Q1 | -305.17 Thousand USD | 4.38% |
| 2009 Q3 | 246.03 Thousand USD | -1.97% |
| 2009 Q4 | 754.77 Thousand USD | 206.77% |
| 2009 FY | - USD | 100.06% |
| 2008 Q1 | -1.24 Million USD | -136.46% |
| 2008 Q2 | -1.18 Million USD | 5.0% |
| 2008 Q3 | 1 Million USD | 184.98% |
| 2008 FY | - USD | -202.09% |
| 2008 Q4 | -319.16 Thousand USD | -131.64% |
| 2007 Q4 | -528.4 Thousand USD | -26.16% |
| 2007 FY | - USD | 230.57% |
| 2007 Q3 | -418.82 Thousand USD | 11.27% |
| 2007 Q2 | -471.99 Thousand USD | -14.11% |
| 2007 Q1 | -413.63 Thousand USD | -278.16% |
| 2006 Q1 | -659.6 Thousand USD | -19.84% |
| 2006 FY | - USD | 36.83% |
| 2006 Q4 | 232.17 Thousand USD | 154.83% |
| 2006 Q3 | -423.43 Thousand USD | 7.88% |
| 2006 Q2 | -459.66 Thousand USD | 30.31% |
| 2005 Q1 | -450.23 Thousand USD | -51.64% |
| 2005 FY | - USD | -138.87% |
| 2005 Q2 | -552.45 Thousand USD | -22.7% |
| 2005 Q3 | -521.62 Thousand USD | 5.58% |
| 2005 Q4 | -550.41 Thousand USD | -5.52% |
| 2004 FY | - USD | 24.01% |
| 2004 Q3 | -148.8 Thousand USD | 43.87% |
| 2004 Q1 | -32.69 Thousand USD | 88.27% |
| 2004 Q2 | -265.13 Thousand USD | -711.04% |
| 2004 Q4 | -296.9 Thousand USD | -99.52% |
| 2003 FY | - USD | 38.95% |
| 2003 Q4 | -530.73 Thousand USD | -10.56% |
| 2003 Q2 | -435.36 Thousand USD | -56.46% |
| 2003 Q3 | -285.2 Thousand USD | 42.11% |
| 2003 Q1 | -276.64 Thousand USD | 64.9% |
| 2002 Q4 | -891.58 Thousand USD | -117.07% |
| 2002 Q3 | -365.2 Thousand USD | -23.69% |
| 2002 Q2 | -392.81 Thousand USD | 30.34% |
| 2002 Q1 | -423.84 Thousand USD | -3364.12% |
| 2002 FY | - USD | -89.12% |
| 2001 Q1 | -5234.00 USD | -120.04% |
| 2001 Q4 | -886.24 Thousand USD | -82.41% |
| 2001 FY | - USD | -63.07% |
| 2001 Q3 | 665.56 Thousand USD | 4002.96% |
| 2001 Q2 | -616.61 Thousand USD | 92.88% |
| 2000 Q2 | -246.82 Thousand USD | -42.61% |
| 2000 Q4 | 132.52 Thousand USD | 144.29% |
| 2000 Q3 | -299.19 Thousand USD | -21.21% |
| 2000 Q1 | -173.07 Thousand USD | 0.0% |
| 2000 FY | - USD | -92.06% |
| 1999 FY | - USD | -8683.55% |
| 1998 FY | - USD | -134.62% |
| 1997 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 12.144% |
| Cerus Corporation | -26.53 Million USD | 55.347% |
| OrthoPediatrics Corp. | -8.38 Million USD | -41.381% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -12.908% |
| Talis Biomedical Corporation | -66.04 Million USD | 82.059% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 28.941% |
| Inogen, Inc. | -45.67 Million USD | 74.06% |
| Spectral AI, Inc. | -12.26 Million USD | 3.367% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 75.155% |
| CVRx, Inc. | -38.73 Million USD | 69.407% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -235.859% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 2.13% |
| Orthofix Medical Inc. | -86.98 Million USD | 86.378% |
| Venus Concept Inc. | -26.11 Million USD | 54.624% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 76.193% |
| Bioventus Inc. | -23.07 Million USD | 48.638% |
| BrainsWay Ltd. | -2.31 Million USD | -412.727% |
| Envoy Medical, Inc. | -18.23 Million USD | 35.031% |
| electroCore, Inc. | -17.76 Million USD | 33.282% |
| IceCure Medical Ltd | -15.25 Million USD | 22.316% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 76.183% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 29.703% |
| MaxCyte, Inc. | -44.12 Million USD | 73.148% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -0.792% |
| Nexalin Technology, Inc. | -5.69 Million USD | -108.17% |
| PAVmed Inc | -75.74 Million USD | 84.356% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 77.958% |
| RxSight, Inc. | -41.03 Million USD | 71.126% |
| Sight Sciences, Inc. | -49.41 Million USD | 76.021% |
| SI-BONE, Inc. | -34.44 Million USD | 65.601% |
| TELA Bio, Inc. | -40.63 Million USD | 70.839% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 79.675% |
| Treace Medical Concepts, Inc. | -39 Million USD | 69.624% |
| LivaNova PLC | 39.01 Million USD | 130.37% |
| 908 Devices Inc. | -34.02 Million USD | 65.175% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 89.286% |
| Nemaura Medical Inc. | -7.28 Million USD | -62.605% |
| NeuroPace, Inc. | -22.83 Million USD | 48.108% |
| LENSAR, Inc. | -8.71 Million USD | -35.978% |
| Apyx Medical Corporation | -18.11 Million USD | 34.579% |
| Cutera, Inc. | -136.56 Million USD | 91.323% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -250.566% |
| BioSig Technologies, Inc. | -28.15 Million USD | 57.909% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 570.951% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 43.546% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 103.089% |
| Axonics, Inc. | 7.77 Million USD | 252.4% |
| Outset Medical, Inc. | -153.78 Million USD | 92.295% |
| IRIDEX Corporation | -7.44 Million USD | -59.091% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 87.921% |
| IRadimed Corporation | 20.8 Million USD | 156.965% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -46.975% |
| INVO Bioscience, Inc. | -6.88 Million USD | -72.225% |
| Telesis Bio, Inc. | -40.49 Million USD | 70.738% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 132.307% |
| Varex Imaging Corporation | 67.2 Million USD | 117.633% |
| Quipt Home Medical Corp. | 44.07 Million USD | 126.886% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -9.008% |
| Pulmonx Corporation | -55.09 Million USD | 78.492% |
| Dynatronics Corporation | -976 Thousand USD | -1114.039% |
| Modular Medical, Inc. | -17.1 Million USD | 30.719% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 18.197% |
| Semler Scientific, Inc. | 23.58 Million USD | 150.232% |
| InMode Ltd. | 196.28 Million USD | 106.037% |
| Bruker Corporation | 599 Million USD | 101.978% |
| Cytosorbents Corporation | -28.81 Million USD | 58.873% |
| DexCom, Inc. | 916.7 Million USD | 101.293% |
| Align Technology, Inc. | 799.03 Million USD | 101.483% |
| Viveve Medical, Inc. | -20.61 Million USD | 42.527% |
| ZimVie Inc. | 91.07 Million USD | 113.011% |
| Movano Inc. | -29.12 Million USD | 59.316% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -168.809% |
| Nexalin Technology, Inc. | -5.69 Million USD | -108.17% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -235.859% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 93.913% |
| Profound Medical Corp. | -27.12 Million USD | 56.314% |
| Insulet Corporation | 323.6 Million USD | 103.662% |
| enVVeno Medical Corporation | -25.01 Million USD | 52.638% |
| Surmodics, Inc. | 1.18 Million USD | 1097.4% |
| iCAD, Inc. | -6.56 Million USD | -80.489% |
| Nuwellis, Inc. | -16.35 Million USD | 27.555% |
| Biotricity, Inc. | -8.82 Million USD | -34.218% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 87.767% |
| InspireMD, Inc. | -20.91 Million USD | 43.335% |
| PAVmed Inc. | -75.74 Million USD | 84.356% |
| BIOLASE, Inc. | -15.13 Million USD | 21.731% |
| Beyond Air, Inc. | -59.03 Million USD | 79.927% |
| FONAR Corporation | 28.25 Million USD | 141.941% |
| AxoGen, Inc. | -13.32 Million USD | 11.096% |
| Vivani Medical, Inc. | -26.6 Million USD | 55.468% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 148.283% |
| Inari Medical, Inc. | 7.11 Million USD | 266.584% |
| UFP Technologies, Inc. | 72.74 Million USD | 116.289% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -249.967% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -92.481% |
| Tenon Medical, Inc. | -15.52 Million USD | 23.692% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 22.382% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 71.431% |
| AdaptHealth Corp. | -171.09 Million USD | 93.074% |
| Sintx Technologies, Inc. | -6.6 Million USD | -79.532% |
| NanoVibronix, Inc. | -3.43 Million USD | -244.952% |
| Quanterix Corporation | -38.08 Million USD | 68.89% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -9.008% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 39597.057% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 95.727% |
| TransMedics Group, Inc. | -7.6 Million USD | -55.848% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 45.559% |
| NeuroMetrix, Inc. | -7.09 Million USD | -66.988% |
| Hyperfine, Inc. | -47.06 Million USD | 74.822% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 79.678% |
| Biomerica, Inc. | -5.99 Million USD | -97.716% |
| Bone Biologics Corporation | 479.57 Thousand USD | 2570.769% |
| AVITA Medical, Inc. | -39.56 Million USD | 70.054% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -29.175% |
| Silk Road Medical, Inc | -45.08 Million USD | 73.715% |